IL-9 induces differentiation of TH17 cells and enhances function of FoxP3⁺ natural regulatory T cells

The development of T helper (TH)17 and regulatory T (Treg) cells is reciprocally regulated by cytokines. Transforming growth factor (TGF)-β alone induces FoxP3⁺ Treg cells, but together with IL-6 or IL-21 induces TH17 cells. Here we demonstrate that IL-9 is a key molecule that affects differentiatio...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 106; no. 31; pp. 12885 - 12890
Main Authors Elyaman, Wassim, Bradshaw, Elizabeth M, Uyttenhove, Catherine, Dardalhon, Valérie, Awasthi, Amit, Imitola, Jaime, Bettelli, Estelle, Oukka, Mohamed, van Snick, Jacques, Renauld, Jean-Christophe, Kuchroo, Vijay K, Khoury, Samia J
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 04.08.2009
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development of T helper (TH)17 and regulatory T (Treg) cells is reciprocally regulated by cytokines. Transforming growth factor (TGF)-β alone induces FoxP3⁺ Treg cells, but together with IL-6 or IL-21 induces TH17 cells. Here we demonstrate that IL-9 is a key molecule that affects differentiation of TH17 cells and Treg function. IL-9 predominantly produced by TH17 cells, synergizes with TGF-β1 to differentiate naïve CD4⁺ T cells into TH17 cells, while IL-9 secretion by TH17 cells is regulated by IL-23. Interestingly, IL-9 enhances the suppressive functions of FoxP3⁺ CD4⁺ Treg cells in vitro, and absence of IL-9 signaling weakens the suppressive activity of nTregs in vivo, leading to an increase in effector cells and worsening of experimental autoimmune encephalomyelitis. The mechanism of IL-9 effects on TH17 and Tregs is through activation of STAT3 and STAT5 signaling. Our findings highlight a role of IL-9 as a regulator of pathogenic versus protective mechanisms of immune responses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: W.E., C.U., J.I., J.V.S., J.-C.R., and S.J.K. designed research; W.E., E.M.B., C.U., V.A.D., A.A., and J.V.S. performed research; C.U., E.B., M.O., J.V.S., J.-C.R., and V.K.K. contributed new reagents/analytic tools; W.E., E.M.B., C.U., V.A.D., and J.V.S. analyzed data; and W.E. wrote the paper.
Edited by Richard A. Flavell, Yale University School of Medicine, New Haven, CT, and approved March 31, 2009
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0812530106